Citation notice #9679 · 2026-08-11 06:34:47.619194+00:00
Visualisation of multi-indication randomised control trial evidence to support decision-making in oncology: a case study on bevacizumab
cites 10.1016/s1470-2045(11)70037-7, which carries a correction notice dated 2011-08-02. One-hop deterministic notice: the citation edge exists in the Pith bibliography graph; no model judged whether the citation was load-bearing.
Citing paper Event page Original DOI Notice DOI File a formal challenge All reference changes
01Evidence
Raw extraction · citation context · bibliography index 10
DOI: 10.1016/j.clbc.2011.03.005. 51. Martín M, Roche H, Pinter T, et al. Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or 26 metastatic breast cancer: A phase 2, randomised, double-blind, placebo-controlled study. Lancet Oncol 2011; 12: 369-376. 20110321. DOI: 10.1016/s1470-2045(11)70037-7. 52. Martín M, Loibl S, von Minckwitz G, et al. Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study. J Clin Oncol 2015; 33: 1045-1052. 20150217. DOI: 10.1200/jco.2014.57.2388. 53. Arteaga CL, Mayer IA, O'Neill AM, et al.
Parser render (TeX stripped for reading; raw above is the evidence)
DOI: 10.1016/j.clbc.2011.03.005. 51. Martín M, Roche H, Pinter T, et al. Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or 26 metastatic breast cancer: A phase 2, randomised, double-blind, placebo-controlled study. Lancet Oncol 2011; 12: 369-376. 20110321. DOI: 10.1016/s1470-2045(11)70037-7. 52. Martín M, Loibl S, von Minckwitz G, et al. Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study. J Clin Oncol 2015; 33: 1045-1052. 20150217. DOI: 10.1200/jco.2014.57.2388. 53. Arteaga CL, Mayer IA, O'Neill AM, et al
02Event
- Type
- Correction
- Source
- Crossref
- Original DOI
- 10.1016/s1470-2045(11)70037-7
- Notice DOI
- 10.1016/s1470-2045(11)70205-4
- Date
- 2011-08-02
- Title
- Errata
- Reasons
- ['Erratum']
- Work
- - (2011)
03Dispute this notice
If this citation does not depend on the flagged claim, or the event is wrong, say so. Disputes are public. For a signed challenge against the paper itself, use the formal challenge form.